Statistics and Risk Assessment Section Roles,
Responsibilities, and Objectives
ElSaadany S
Draft: Oct. 19, 2007
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
Decision Analysis: Effective Hepatitis B Screening of
New Entrants to Canada, Based on a One-Year Cohort of
Immigrants.
ElSaadany S
Update: 2007
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
On the Performance of Social Network and Likelihood
Based Expert Weighting Schemes.
Roger M. Cooke, Susie, ElSaadany (Co-Author), Xinzheng Huang
Decision Analysis, 2006
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
Epidemiology of hepatocellular carcinoma in Canada,
1995: Analysis of death certificates.
ElSaadany S, Guilivi A.
Chronic Diseases in Canada, Volume 27, No 3, 2006
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
Economic Burden of Hepatitis C in Canada and the
Potential Impact of Prevention: Results from a Disease
Model.
ElSaadany S, Coyle D, Guilivi A.
Journal of Health Economics. June 2005
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
A vCJD Risk-Assessment Case Study: A Preliminary
Quantitative Assessment of Canadian Vaccines Incorporating Bovine
Biological Materials In Their Manufacture.
ElSaadany S, Giulivi A.
Bioprocess International. March 2005
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
Modeling Rare and Emerging Diseases for Decision Making
and Policy Implementation: Extreme Values and Data
Management.
ElSaadany S, Guilivi A, Hanna N.
Bioprocess International. January 2004
Email Dr. Susie ElSaadany or Caroline Desjardins to receive the abstract
An epidemiologic study of hepatocellular carcinoma in
Canada.
ElSaadany S, Tepper M, Mao Y, Semenciw R, Giulivi A.
Can J Public Health 2002;93(6):443-46.
Email Dr. Susie ElSaadany for further information.